Peripheral Neuropathy Trial, Recruiting NCT07543692 Sponsor: Jaseng Medical Foundation Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07543692
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a spinal condition (such as a spine-related disease or spinal injury).
  • People whose pain score is 5 or higher (out of 10) for their main pain — either neck pain spreading into the arm, or lower back pain spreading into the leg.
  • People (whether seen as outpatients or staying in hospital) who are already scheduled to have an ultrasound-guided pharmacopuncture procedure as part of their normal care, based on their doctor's clinical judgment.
  • People who are willing to take part in the study and sign a consent form agreeing to participate.

Who may not be able to join:

  • People who have difficulty completing a written consent form.
  • Women who are pregnant, trying to become pregnant, or currently breastfeeding.
  • People who have a serious underlying health condition — such as cancer or another serious illness — that the study doctor believes could affect treatment results or make participation unsuitable.
  • People who the study doctor considers unsuitable for participation for any other reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: In-Hyuk Ha, Dr, Jaseng Medical Foundation

Phone: +82-1577-0007

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jaseng Medical Foundation
Registry
ClinicalTrials.gov
Start date
29 April 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Change in Pain Intensity : Numeric Rating Scale (NRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov